OverviewSuggest Edit

Echo Therapeutics is developing its non-invasive (transdermal & without needles), wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the diabetes fitness, weight loss and personal lifestyle wearable-health space. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.

TypePublic
Founded1989
HQWoodbridge Township, US
Websiteechotx.com

Locations

Echo Therapeutics is headquartered in
Woodbridge Township, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)19
Revenue (FY, 2013)$27.6 K
Share Price (Oct 2017)$0

Echo Therapeutics Office Locations

Echo Therapeutics has an office in Woodbridge Township
Woodbridge Township, US (HQ)
99 S Wood Ave #302, Iselin
Show all (1)

Echo Therapeutics Financials and Metrics

Echo Therapeutics Revenue

Echo Therapeutics's revenue was reported to be $27.60 k in FY, 2013
USD

Net income (Q3, 2016)

794.2k

EBIT (Q3, 2016)

(1.8m)

Market capitalization (5-Oct-2018)

95.5k

Cash (30-Sep-2016)

172.7k
Echo Therapeutics's current market capitalization is $95.5 k.
Annual
USDFY, 2013FY, 2015

Revenue

27.6k

General and administrative expense

8.4m4.3m

R&D expense

11.3m2.8m

Operating expense total

19.7m17.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q3, 2016

Revenue

22.6k19.1k19.1k19.1k

General and administrative expense

2.2m1.5m2.2m1.7m1.4m739.1k1.2m

R&D expense

2.8m1.1m1.7m1.2m797.8k640.6k588.6k

Operating expense total

4.9m2.7m3.9m2.9m12.3m1.5m1.8m
Annual
USDFY, 2013FY, 2014FY, 2015

Cash

8.1m1.3m56.2k

Inventories

49.2k490.8k

Current Assets

9.4m1.8m300.7k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q3, 2016

Cash

6.1m7.1m4.1m1.5m337.4k3.2k172.7k

Current Assets

7.8m8.2m5.3m1.8m680.4k226.7k402.0k

PP&E

443.4k302.0k188.9k

Total Assets

21.9m21.6m18.4m12.6m1.3m765.4k1.1m
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

(19.1m)(15.0m)(22.2m)

Depreciation and Amortization

391.6k392.7k521.9k

Inventories

26.4k(441.6k)

Accounts Payable

(1.3m)765.1k656.6k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q3, 2016

Net Income

(15.6m)(2.8m)(6.5m)(12.0m)(19.1m)(20.9m)(4.8m)

Depreciation and Amortization

288.9k99.9k198.8k296.7k448.3k487.5k85.1k

Accounts Payable

(768.1k)(332.1k)(4.0k)(130.7k)(5.5k)396.0k(152.2k)

Cash From Operating Activities

(16.2m)(3.2m)(6.5m)(9.1m)(3.2m)(4.2m)(4.2m)
USDY, 2016

Financial Leverage

-0.2 x
Show all financial metrics

Echo Therapeutics Online and Social Media Presence

Embed Graph

Echo Therapeutics Frequently Asked Questions

  • When was Echo Therapeutics founded?

    Echo Therapeutics was founded in 1989.

  • How many employees does Echo Therapeutics have?

    Echo Therapeutics has 19 employees.

  • Who are Echo Therapeutics competitors?

    Competitors of Echo Therapeutics include POPS! Diabetes Care, Insulet and Neurometrix.

  • Where is Echo Therapeutics headquarters?

    Echo Therapeutics headquarters is located at 99 S Wood Ave #302, Iselin, Woodbridge Township.

  • Where are Echo Therapeutics offices?

    Echo Therapeutics has an office in Woodbridge Township.

  • How many offices does Echo Therapeutics have?

    Echo Therapeutics has 1 office.